Breakthrough study uses chromosome physical properties to monitor breast cancer therapy outcomes and predict recurrence ...

The global therapeutic drug monitoring market is poised for significant expansion, with projections indicating a rise from USD 1,203.9 million in 2024 to an impressive USD 2,527.9 million by 2034.

Evinova has partnered with QLHC to incorporate its RPM solution into the I-SPY 2.2 trial of various breast cancer treatments.

Background Voriconazole is approved for treatment of invasive aspergillosis and other invasive fungal infections, but the role for therapeutic drug monitoring (TDM) is not clear. Methods We ...

PhD Defense: Advancing Therapeutic Drug Monitoring of oral targeted anticancer drugs; analytical and clinical studies ...

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is one of the most aggressive forms of skin cancer, with current ...

Gold nanoparticles (AuNPs) have emerged as promising drug carriers for cancer therapy and targeted drug delivery but tracking ...

Gold nanoparticles are promising drug carriers for cancer therapy and targeted drug delivery, but tracking the movement of ...

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is one of the most ...

A research team has developed an innovative technique that enables precise modification of specific proteins within complex biological environments.